Skip to content
2000
Volume 21, Issue 4
  • ISSN: 1573-3971
  • E-ISSN: 1875-6360

Abstract

Background

In Rheumatoid Arthritis (RA), pulmonary involvement is one of the most frequent extra-articular manifestations. Several studies have demonstrated an association between RA-related lung disease and the positivity of anti-cyclic citrullinated peptide (anti-CCP) antibodies.

Objective

Our aim is to describe the frequency of pulmonary involvement in the RA population and investigate the association between anti-CCP antibodies and diverse lung compartment involvement in RA patients.

Methods

An observational retrospective cross-sectional study was conducted, during which data were collected from the medical records of the patients with RA who had been tested for anti-CCP antibodies and had thoracic high resolution computerized tomography (HRCT) evaluation from January 2011 to March 2022. The univariate and multivariate analyses using logistic regression models was performed to calculate odds ratios (ORs) with 95% CIs.

Results

A total of 390 patients with RA were included, the mean age of patients was 58.99 ± 12.44 years, with a predominance of females (85.9%). Two hundred and fifty-two (64.6%) patients were positive for anti-CCP antibodies. The frequency of RA-related lung diseases was 14.4% (n=56). The different manifestations observed in the thoracic HRCT included Nodules (67.9%), Interstitial lung disease (ILD) (28.6%), bronchiectasis (25%), fibrosis (21.4%), obliterative bronchiolitis (7.1%), and pleuritis (1.8%). In univariate and multivariate analysis, pulmonary involvement was associated with positive anti-CCP antibodies with an odds ratio (OR) of 5.25 (95% CI: 2.17-12.70, < 0.0001).

Conclusion

The study demonstrated a positive association between anti-CCP antibodies and pulmonary involvement in RA and highlighted the importance of tight monitoring in RA patients with positive anti-CCP for pulmonary complications.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/crr/10.2174/0115733971298865240812063200
2024-09-12
2025-09-08

  • From This Site

    /content/journals/crr/10.2174/0115733971298865240812063200
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. BullockJ. RizviS.A.A. SalehA.M. AhmedS.S. DoD.P. AnsariR.A. AhmedJ. Rheumatoid Arthritis: A brief overview of the treatment.Med. Princ. Pract.201827650150710.1159/00049339030173215
     [Google Scholar]
  2. YoungA. KoduriG. Extra-articular manifestations and complications of rheumatoid arthritis.Best Pract. Res. Clin. Rheumatol.200721590792710.1016/j.berh.2007.05.00717870035
     [Google Scholar]
  3. KhanT. JoseR.J. RenzoniE.A. MouyisM. A closer look at the role of anti-CCP antibodies in the pathogenesis of rheumatoid arthritis-associated interstitial lung disease and bronchiectasis.Rheumatol. Ther.2021841463147510.1007/s40744‑021‑00362‑434449068
     [Google Scholar]
  4. GauharU. GaffoA. AlarcónG. Pulmonary manifestations of rheumatoid arthritis.Semin. Respir. Crit. Care Med.200728443044010.1055/s‑2007‑98566417764060
     [Google Scholar]
  5. JugeP.A. GrangerB. DebrayM.P. EbsteinE. Louis-SidneyF. KedraJ. DoyleT.J. BorieR. ConstantinA. CombeB. FlipoR.M. MarietteX. VittecoqO. SarauxA. Carvajal-AlegriaG. SibiliaJ. BerenbaumF. KannengiesserC. BoileauC. SparksJ.A. CrestaniB. FautrelB. DieudéP. A risk score to detect subclinical rheumatoid arthritis–associated interstitial lung disease.Arthritis Rheumatol.202274111755176510.1002/art.4216235583934
     [Google Scholar]
  6. JugeP.A. LeeJ.S. EbsteinE. FurukawaH. DobrinskikhE. GazalS. KannengiesserC. OttavianiS. OkaS. TohmaS. TsuchiyaN. Rojas-SerranoJ. González-PérezM.I. MejíaM. Buendía-RoldánI. Falfán-ValenciaR. Ambrocio-OrtizE. ManaliE. PapirisS.A. KarageorgasT. BoumpasD. AntoniouK. van MoorselC.H.M. van der VisJ. de ManY.A. GruttersJ.C. WangY. BorieR. Wemeau-StervinouL. WallaertB. FlipoR.M. NunesH. ValeyreD. Saidenberg-Kermanac’hN. BoissierM.C. Marchand-AdamS. FrazierA. RichetteP. AllanoreY. SibiliaJ. DromerC. RichezC. SchaeverbekeT. LiotéH. ThabutG. NathanN. AmselemS. SoubrierM. CottinV. ClémentA. DeaneK. WaltsA.D. FingerlinT. FischerA. RyuJ.H. MattesonE.L. NiewoldT.B. AssayagD. GrossA. WoltersP. SchwarzM.I. HolersM. SolomonJ.J. DoyleT. RosasI.O. BlauwendraatC. NallsM.A. DebrayM.P. BoileauC. CrestaniB. SchwartzD.A. DieudéP. MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease.N. Engl. J. Med.2018379232209221910.1056/NEJMoa180156230345907
     [Google Scholar]
  7. LiL. LiuR. ZhangY. ZhouJ. LiY. XuY. GaoS. ZhengY. A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease.Clin. Rheumatol.20203951457147010.1007/s10067‑019‑04846‑131858341
     [Google Scholar]
  8. ChoiWI DautiS KimHJ ParkSH ParkJS LeeCW Risk factors for interstitial lung disease: A 9-year Nationwide population-based study.BMC Pulmonary Med20181896066010.1186/s12890‑018‑0660‑2
     [Google Scholar]
  9. OkaS HiguchiT FurukawaH Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis.BMC Musculoskelet Disord.2022234610.1186/s12891‑021‑04985‑0
     [Google Scholar]
  10. PerryE. KellyC. EggletonP. De SoyzaA. HutchinsonD. The lung in ACPA-positive rheumatoid arthritis: An initiating site of injury?Rheumatology (Oxford)201453111940195010.1093/rheumatology/keu19524831057
     [Google Scholar]
  11. Haj HensvoldA. MagnussonP.K.E. JoshuaV. HanssonM. IsraelssonL. FerreiraR. JakobssonP.J. HolmdahlR. HammarströmL. MalmströmV. AsklingJ. KlareskogL. CatrinaA.I. Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: An epidemiological investigation in twins.Ann. Rheum. Dis.201574237538010.1136/annrheumdis‑2013‑20394724276366
     [Google Scholar]
  12. ZhangM YinJ ZhangX Factors associated with interstitial lung disease in patients with rheumatoid arthritis: A systematic review and meta-analysis.PLoS One2023186e028619110.1371/journal.pone.0286191
     [Google Scholar]
  13. ArnettF.C. EdworthyS.M. BlochD.A. McshaneD.J. FriesJ.F. CooperN.S. HealeyL.A. KaplanS.R. LiangM.H. LuthraH.S. MedsgerT.A.Jr MitchellD.M. NeustadtD.H. PinalsR.S. SchallerJ.G. SharpJ.T. WilderR.L. HunderG.G. The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis.Arthritis Rheum.198831331532410.1002/art.17803103023358796
     [Google Scholar]
  14. AletahaD. NeogiT. SilmanA.J. FunovitsJ. FelsonD.T. BinghamC.O.III BirnbaumN.S. BurmesterG.R. BykerkV.P. CohenM.D. CombeB. CostenbaderK.H. DougadosM. EmeryP. FerraccioliG. HazesJ.M.W. HobbsK. HuizingaT.W.J. KavanaughA. KayJ. KvienT.K. LaingT. MeaseP. MénardH.A. MorelandL.W. NadenR.L. PincusT. SmolenJ.S. Stanislawska-BiernatE. SymmonsD. TakP.P. UpchurchK.S. VencovskýJ. WolfeF. HawkerG. 2010 rheumatoid arthritis classification criteria: An american college of rheumatology/european league against rheumatism collaborative initiative.Arthritis Rheum.20106292569258110.1002/art.2758420872595
     [Google Scholar]
  15. PrevooM.L.L. Van’T HofM.A. KuperH.H. Van LeeuwenM.A. Van De PutteL.B.A. Van RielP.L.C.M. Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.Arthritis Rheum.1995381444810.1002/art.17803801077818570
     [Google Scholar]
  16. DuarteA.C. PorterJ.C. LeandroM.J. The lung in a cohort of rheumatoid arthritis patients—an overview of different types of involvement and treatment.Rheumatology (Oxford)201958112031203810.1093/rheumatology/kez17731089697
     [Google Scholar]
  17. DahaniA AamerN SeeraniNL KarimMT KhanF ArainSR Pulmonary manifestations in patients with rheumatoid arthritis visiting tertiary care hospital.J Ayub Med Coll Abbottabad202234Suppl 1S991S99410.55519/JAMC‑04‑S4‑9714
     [Google Scholar]
  18. BilgiciA. UlusoyH. KuruO. ÇelenkÇ. ÜnsalM. DanacıM. Pulmonary involvement in rheumatoid arthritis.Rheumatol. Int.200525642943510.1007/s00296‑004‑0472‑y16133582
     [Google Scholar]
  19. HuangS. KronzerV.L. DellaripaP.F. DeaneK.D. BolsterM.B. NagarajaV. KhannaD. DoyleT.J. SparksJ.A. Rheumatoid arthritis-associated interstitial lung disease: Current update on prevalence, risk factors, and pharmacologic treatment.Curr. Treatm. Opt. Rheumatol.20206433735310.1007/s40674‑020‑00160‑z33282632
     [Google Scholar]
  20. BergströmU. JacobssonL.T.H. NilssonJ.A. BerglundG. TuressonC. Pulmonary dysfunction, smoking, socioeconomic status and the risk of developing rheumatoid arthritis.Rheumatology (Oxford)201150112005201310.1093/rheumatology/ker25821859698
     [Google Scholar]
  21. RichmanN.C. YazdanyJ. GrafJ. ChernitskiyV. ImbodenJ.B. Extraarticular manifestations of rheumatoid arthritis in a multiethnic cohort of predominantly Hispanic and Asian patients.Medicine (Baltimore)2013922929710.1097/MD.0b013e318289ce0123429352
     [Google Scholar]
  22. SalaffiF. CarottiM. Di CarloM. TardellaM. GiovagnoniA. High- resolution computed tomography of the lung in patients with rheumatoid arthritis.Medicine (Baltimore)20199838e1708810.1097/MD.000000000001708831567944
     [Google Scholar]
  23. ChenJ. ShiY. WangX. HuangH. AschermanD. Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease.Clin. Dev. Immunol.201320131510.1155/2013/40692723983768
     [Google Scholar]
  24. GilesJ.T. DanoffS.K. SokoloveJ. WagnerC.A. WinchesterR. PappasD.A. SiegelmanS. ConnorsG. RobinsonW.H. BathonJ.M. Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease.Ann. Rheum. Dis.20147381487149410.1136/annrheumdis‑2012‑20316023716070
     [Google Scholar]
  25. YinY LiangD ZhaoL Anti-cyclic citrullinated Peptide antibody is associated with interstitial lung disease in patients with rheumatoid arthritis.PLoS One201494e9244910.1371/journal.pone.0092449
     [Google Scholar]
  26. FischerA. SolomonJ.J. du BoisR.M. DeaneK.D. OlsonA.L. Fernandez-PerezE.R. HuieT.J. StevensA.D. GillM.B. RabinovitchA.M. LynchD.A. BurnsD.A. PineiroI.S. GroshongS.D. Duarte AchcarR.D. BrownK.K. MartinR.J. SwigrisJ.J. Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease.Respir. Med.201210671040104710.1016/j.rmed.2012.03.00622503074
     [Google Scholar]
  27. KatsumataM. HozumiH. YasuiH. SuzukiY. KonoM. KarayamaM. FuruhashiK. EnomotoN. FujisawaT. InuiN. NakamuraY. SudaT. Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias.Respir. Med.201915410210810.1016/j.rmed.2019.06.01631229943
     [Google Scholar]
  28. KamiyaH PanlaquiOM Systematic review and meta-analysis of the risk of rheumatoid arthritis-associated interstitial lung disease related to anti-cyclic citrullinated peptide (CCP) antibody.BMJ Open202113e04046510.1136/bmjopen‑2020‑040465
     [Google Scholar]
  29. AlunnoA. BistoniO. PratesiF. La PagliaG.M.C. PuxedduI. MiglioriniP. GerliR. Anti-citrullinated alpha enolase antibodies, interstitial lung disease and bone erosion in rheumatoid arthritis.Rheumatology (Oxford)201857585085510.1093/rheumatology/kex52029452423
     [Google Scholar]
  30. LiuY. LiuC. LiL. ZhangF. LiY. ZhangS. High levels of antibodies to citrullinated α-enolase peptide-1 (CEP-1) identify erosions and interstitial lung disease (ILD) in a Chinese rheumatoid arthritis cohort.Clin. Immunol.2019200101510.1016/j.clim.2019.01.00130611755
     [Google Scholar]
  31. LiaoK.P. SparksJ.A. HejblumB.P. KuoI.H. CuiJ. LaheyL.J. CaganA. GainerV.S. LiuW. CaiT.T. SokoloveJ. CaiT. Phenome-wide association study of autoantibodies to citrullinated and noncitrullinated epitopes in rheumatoid arthritis.Arthritis Rheumatol.201769474274910.1002/art.3997427792870
     [Google Scholar]
  32. EnglandB.R. DuryeeM.J. RoulP. MahajanT.D. SinghN. PooleJ.A. AschermanD.P. CaplanL. DemoruelleM.K. DeaneK.D. KlassenL.W. ThieleG.M. MikulsT.R. Malondialdehyde–acetaldehyde adducts and antibody responses in rheumatoid arthritis–associated interstitial lung disease.Arthritis Rheumatol.20197191483149310.1002/art.4090030933423
     [Google Scholar]
  33. HarlowL. RosasI.O. GochuicoB.R. MikulsT.R. DellaripaP.F. OddisC.V. AschermanD.P. Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease.Arthritis Rheum.201365486987910.1002/art.3788123400887
     [Google Scholar]
  34. KronzerV.L. HayashiK. YoshidaK. DavisJ.M.III McDermottG.C. HuangW. DellaripaP.F. CuiJ. FeathersV. GillR.R. HatabuH. NishinoM. BlausteinR. CrowsonC.S. RobinsonW.H. SokoloveJ. LiaoK.P. WeinblattM.E. ShadickN.A. DoyleT.J. SparksJ.A. Autoantibodies against citrullinated and native proteins and prediction of rheumatoid arthritis-associated interstitial lung disease: A nested case–control study.Lancet Rheumatol.202352e77e8710.1016/S2665‑9913(22)00380‑036874209
     [Google Scholar]
  35. JoshuaV. HensvoldA.H. ReynisdottirG. HanssonM. CornilletM. NogueiraL. SerreG. NyrenS. KarimiR. EklundA. SköldM. GrunewaldJ. ChatzidionysiouK. CatrinaA. Association between number and type of different ACPA fine specificities with lung abnormalities in early, untreated rheumatoid arthritis.RMD Open202062e00127810.1136/rmdopen‑2020‑00127832917833
     [Google Scholar]
  36. XieS. LiS. ChenB. ZhuQ. XuL. LiF. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis–related interstitial lung disease: A meta-analysis.Clin. Rheumatol.202140114533454310.1007/s10067‑021‑05808‑234189672
     [Google Scholar]
  37. ShidaraK. HoshiD. InoueE. YamadaT. NakajimaA. TaniguchiA. HaraM. MomoharaS. KamataniN. YamanakaH. Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA.Mod. Rheumatol.201020328028610.3109/s10165‑010‑0280‑z20217173
     [Google Scholar]
  38. PaulinF. DoyleT.J. MercadoJ.F. FassolaL. FernándezM. CaroF. AlbertiM.L. EspíndolaM.E.C. BuschiazzoE. Development of a risk indicator score for the identification of interstitial lung disease in patients with rheumatoid arthritis.Reumatología Clínica (English Edition)202117420721110.1016/j.reumae.2019.05.00631420237
     [Google Scholar]
  39. SeveroC.R. ChomiskiC. ValleM.B.D. EscuissatoD.L. PaivaE.D.S. StorrerK.M. Assessment of risk factors in patients with rheumatoid arthritis-associated interstitial lung disease.J. Bras. Pneumol.2022486e2022014510.36416/1806‑3756/e2022014536477171
     [Google Scholar]
  40. KielyP BusbyAD NikiphorouE Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts.BMJ Open201995e02846610.1136/bmjopen‑2018‑028466
     [Google Scholar]
  41. ConwayR LowC CoughlanRJ O'DonnellMJ CareyJJ Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: Systematic literature review and meta-analysis of randomised controlled trials.BMJ20153505h126910.1136/bmj.h1269
     [Google Scholar]
  42. NarváezJ. AburtoM. Seoane-MatoD. BonillaG. AcostaO. CandelasG. Cano-JiménezE. CastellvíI. González-RuizJ.M. CorominasH. López-MuñizB. Martín-LópezM. Robles-PérezA. Mena-VázquezN. Rodríguez-PortalJ.A. OrtizA.M. Sabater-AbadC. CastrejónI. dos SantosR. Garrote-CorralS. MaeseJ. Silva-FernándezL. CastañedaS. ValenzuelaC. Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology.Reumatología Clínica (English Edition)2023192748110.1016/j.reumae.2021.12.00335753951
     [Google Scholar]
/content/journals/crr/10.2174/0115733971298865240812063200
Loading
What is the Link between Lung Involvement and Anti-CCP Antibodies in Rheumatoid Arthritis: A Cross-sectional Study
Curr. Rheumatol. Rev. 21, 410 (2025); https://doi.org/10.2174/0115733971298865240812063200
/content/journals/crr/10.2174/0115733971298865240812063200
/content/journals/crr/10.2174/0115733971298865240812063200
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): Anti-cyclic citrullinated peptide antibodies; ILD; lung; methotrexate; pulmonary involvement; rheumatoid arthritis; smoking; thoracichigh-resolution computerized tomography

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test